SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-21-000607
Filing Date
2021-07-29
Accepted
2021-07-29 16:01:13
Documents
14
Period of Report
2021-07-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K alec-20210729.htm   iXBRL 8-K 44996
2 EX-99.1 alec-20210729ex99_1.htm EX-99.1 89687
3 GRAPHIC img60799751_0.jpg GRAPHIC 57391
  Complete submission text file 0000950170-21-000607.txt   343659

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alec-20210729_lab.xml EX-101.LAB 13496
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alec-20210729_pre.xml EX-101.PRE 9977
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alec-20210729.xsd EX-101.SCH 2426
7 EXTRACTED XBRL INSTANCE DOCUMENT alec-20210729_htm.xml XML 4692
Mailing Address 151 OYSTER POINT BLVD., SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD., SUITE 300 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Filer) CIK: 0001653087 (see all company filings)

IRS No.: 462702363 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38792 | Film No.: 211127289
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences